Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small a… Read more
Bioqual Inc (BIOQ) - Total Assets
Latest total assets as of November 2025: $72.74 Million USD
Based on the latest financial reports, Bioqual Inc (BIOQ) holds total assets worth $72.74 Million USD as of November 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bioqual Inc - Total Assets Trend (1996–2025)
This chart illustrates how Bioqual Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bioqual Inc - Asset Composition Analysis
Current Asset Composition (May 2025)
Bioqual Inc's total assets of $72.74 Million consist of 54.8% current assets and 45.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 31.3% |
| Accounts Receivable | $13.16 Million | 23.1% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $1.03 Million | 1.8% |
Asset Composition Trend (1996–2025)
This chart illustrates how Bioqual Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bioqual Inc's current assets represent 54.8% of total assets in 2025, an increase from 46.6% in 1996.
- Cash Position: Cash and equivalents constituted 31.3% of total assets in 2025, up from 5.2% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 23.1% of total assets.
Bioqual Inc Competitors by Total Assets
Key competitors of Bioqual Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Bioqual Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Bioqual Inc generates 0.86x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bioqual Inc is currently not profitable relative to its asset base.
Bioqual Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.41 | 3.73 | 4.09 |
| Quick Ratio | 4.41 | 3.73 | 4.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $19.75 Million | $ 22.03 Million | $ 19.95 Million |
Bioqual Inc - Advanced Valuation Insights
This section examines the relationship between Bioqual Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.57 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | $57.12 Million |
| Market Capitalization | $11.52 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bioqual Inc's assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bioqual Inc's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bioqual Inc (1996–2025)
The table below shows the annual total assets of Bioqual Inc from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | $57.12 Million | +0.94% |
| 2024-05-31 | $56.59 Million | -7.71% |
| 2023-05-31 | $61.32 Million | -3.20% |
| 2022-05-31 | $63.34 Million | +18.57% |
| 2021-05-31 | $53.42 Million | +7.81% |
| 2020-05-31 | $49.55 Million | +75.02% |
| 2019-05-31 | $28.31 Million | +7.62% |
| 2018-05-31 | $26.30 Million | +15.58% |
| 2017-05-31 | $22.76 Million | +17.15% |
| 2016-05-31 | $19.43 Million | +11.89% |
| 2015-05-31 | $17.36 Million | +12.19% |
| 2014-05-31 | $15.48 Million | +31.27% |
| 2013-05-31 | $11.79 Million | -11.33% |
| 2011-05-31 | $13.30 Million | +8.70% |
| 2010-05-31 | $12.23 Million | +20.50% |
| 2007-05-31 | $10.15 Million | +16.85% |
| 2006-05-31 | $8.69 Million | -5.17% |
| 2005-05-31 | $9.16 Million | +20.20% |
| 2004-05-31 | $7.62 Million | +27.72% |
| 2003-05-31 | $5.97 Million | +22.44% |
| 2001-05-31 | $4.87 Million | -8.48% |
| 2000-05-31 | $5.33 Million | +15.19% |
| 1999-05-31 | $4.62 Million | +8.11% |
| 1998-05-31 | $4.28 Million | -8.90% |
| 1997-05-31 | $4.69 Million | +10.96% |
| 1996-05-31 | $4.23 Million | -- |